$9.70
-0.02[-0.21%]
At close: Apr 26
$9.70
0[0.00%]
After Hours: 7:14PM EDT
Precision BioSciences
(NASDAQ:DTIL)Latest News for Precision BioSciences Stock (NASDAQ:DTIL)
Precision BioSciences Stock (NASDAQ: DTIL)
Categories: All
Wednesday, April 17, 2024
Tuesday, April 16, 2024
Thursday, March 28, 2024
Wednesday, March 27, 2024
- Precision Biosciences' 2023 Cash And Cash Equivalents Of $116.7M, Cash Received From TG Therapeutics, Caribou Of $50M, And $40M Capital Raise Is Expected To Provide Cash Runway Into 2H Of 2026Benzinga Newsdesk - Mar 27, 2024, 6:58AM
- Precision BioSciences Q4 GAAP EPS $(4.06) May Not Be Comparable To $(2.05) Estimate, Sales $7.04M Miss $12.48M EstimateBenzinga Newsdesk - Mar 27, 2024, 6:48AM
- Earnings Scheduled For March 27, 2024Benzinga Insights - Mar 27, 2024, 5:02AM
Tuesday, March 26, 2024
Wednesday, March 06, 2024
Friday, March 01, 2024
- Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Mar 1, 2024, 1:19PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Mar 1, 2024, 12:34PM
- Precision BioSciences shares are trading lower after the company announced a $40 million offering of common stock and warrants.Benzinga Newsdesk - Mar 1, 2024, 10:55AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Mar 1, 2024, 8:09AM
- Precision BioSciences Discloses $40M Offering of Common Stock And Warrants, Warrants Have An Exercise Price Of $20.00 Per Share And Are Exercisable ImmediatelyBenzinga Newsdesk - Mar 1, 2024, 6:40AM
Thursday, February 29, 2024
Tuesday, February 27, 2024
Tuesday, February 20, 2024
Wednesday, February 14, 2024
- HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $3 Price TargetBenzinga Newsdesk - Feb 14, 2024, 1:42PM
- Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Feb 14, 2024, 8:55AM
- Precision BioSciences Receives Pre-IND Feedback From FDA For PBGENE-HBV As It Advances Towards Clinical ReadinessBenzinga Newsdesk - Feb 14, 2024, 7:15AM
Tuesday, February 13, 2024
Friday, February 09, 2024
Tuesday, January 30, 2024
Wednesday, January 10, 2024
Tuesday, January 09, 2024
- Precision BioSciences shares are trading higher after the company announced it completed a license deal with TG Therapeutics to develop Azer-Cel for autoimmune diseases.Benzinga Newsdesk - Jan 9, 2024, 12:01PM
- Why Precision BioSciences Stock Is Up TodayErica Kollmann - Jan 9, 2024, 11:39AM
- Precision BioSciences Strikes $17.5M Gene Editing Deal with TG Therapeutics, Eyeing $288M in Future MilestonesBenzinga Newsdesk - Jan 9, 2024, 7:05AM
Wednesday, December 13, 2023
Tuesday, December 05, 2023
Tuesday, November 07, 2023
- Precision BioSciences' Q3 Cash Balance Of $122.2M, Expected To Provide Extended Cash Runway Through The End Of 2025Benzinga Newsdesk - Nov 7, 2023, 7:19AM
- Precision BioSciences Q3 EPS $(0.07) Beats $(0.17) Estimate, Sales $13.12M Beat $8.60M EstimateBenzinga Newsdesk - Nov 7, 2023, 7:18AM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Monday, November 06, 2023
Wednesday, November 01, 2023
Thursday, October 26, 2023
Tuesday, October 03, 2023
Monday, October 02, 2023
Tuesday, September 26, 2023
Tuesday, September 19, 2023
Tuesday, September 12, 2023
Friday, September 08, 2023
Thursday, August 17, 2023
- What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify ValuationVandana Singh - Aug 17, 2023, 2:18PM
- Precision BioSciences shares are trading lower after HC Wainwright maintained a Buy rating on the stock but lowered its price target from $5 to $3.Benzinga Newsdesk - Aug 17, 2023, 11:06AM
- The Latest Analyst Ratings for Precision BioSciencesBenzinga Insights - Aug 17, 2023, 9:00AM